CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 834210124
- Phone
- 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,567,247
- in 1 filing
Net −$3,567,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-01 | Chen Po Yu (Jeff) Director | Grant or award · Stock Option (right to buy) | +30,574 | 30,574 | ||
| 2024-02-01 | Chen Po Yu (Jeff) Director | Grant or award · Stock Option (right to buy) | +1,540 | $11.88 | $18K | 1,540 |
| 2024-02-01 | Cox Christopher Nixon Director | Grant or award · Stock Option (right to buy) | +30,574 | 30,574 | ||
| 2024-02-01 | Cox Christopher Nixon Director | Grant or award · Stock Option (right to buy) | +4,623 | $11.88 | $55K | 4,623 |
| 2024-02-01 | Dreyfus Andrew Director | Grant or award · Stock Option (right to buy) | +30,574 | 30,574 |
Page 7 of 7 · 125 trades